The London healthtech startup secured backing from Balderton and Pentland to scale manufacturing and regulatory pathways for its continuous glucose monitor.
"During their time at Imperial, they worked in one of the pioneering research groups that invented modern glucose strip technology. Their combined expertise in electrochemistry, biosensing, and medical device engineering laid the foundation for Sava’s next-generation biosensor platform."
The pre-seed round was led by 42Cap with participation from Insurtech Gateway to accelerate product development.
"Novee is building the AI intelligence layer for underwriting, giving insurers the speed, clarity and control they need to assess complex risks with confidence. With support from 42Cap and Insurtech Gateway, and in close collaboration with leading insurers, we’re not just streamlining underwriting workflows but helping our customers unlock growth and write better business. This funding allows us to accelerate product development, expand across other classes of business and deepen our partnerships with leading insurers."
The oversubscribed funding round will support the artificial intelligence startup as it opens its closed beta.
"Thanks to AI, scheduling doesn’t have to be so rigid any longer. Software can now adapt to us – our routines, our changes, and our painfully dynamic calendars."
The pre-seed round was led by the British Business Bank and the Games Angels to advance product development and drive commercial expansion.
"JECO was born out of the belief that if developers are given frictionless ways to improve and enhance their development processes, they can find quicker, cost effective routes to market, and can also start to play an important role in addressing wider environmental issues that may impact our industry in the future. I am incredibly grateful to all our investors for supporting us in our mission; to support developers in making positive behavioural changes through the power of technology."